Jordan Elm
Jordan Elm
Professor of Biostatistics, Medical University of South Carolina
Email confirmado em
Citado por
Citado por
Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA
SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ...
New England Journal of Medicine 379 (3), 215-225, 2018
Evolution of the modified Rankin scale and its use in future stroke trials
JP Broderick, O Adeoye, J Elm
Stroke 48 (7), 2007-2012, 2017
Randomized trial of three anticonvulsant medications for status epilepticus
J Kapur, J Elm, JM Chamberlain, W Barsan, J Cloyd, D Lowenstein, ...
New England Journal of Medicine 381 (22), 2103-2113, 2019
The impact of depressive symptoms in early Parkinson disease
B Ravina, R Camicioli, PG Como, L Marsh, J Jankovic, D Weintraub, ...
Neurology 69 (4), 342-347, 2007
Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA
SC Johnston, JD Easton, M Farrant, W Barsan, RA Conwit, JJ Elm, ...
N Engl J Med 379 (3), 215-225, 2018
Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial
KN Sheth, JJ Elm, BJ Molyneaux, H Hinson, LA Beslow, GK Sze, ...
The Lancet Neurology 15 (11), 1160-1169, 2016
Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling …
Y Pan, JJ Elm, H Li, JD Easton, Y Wang, M Farrant, X Meng, AS Kim, ...
JAMA neurology 76 (12), 1466-1473, 2019
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial
JM Chamberlain, J Kapur, S Shinnar, J Elm, M Holsti, L Babcock, ...
The Lancet 395 (10231), 1217-1224, 2020
Transcranial direct current stimulation vs sham stimulation to treat aphasia after stroke: a randomized clinical trial
J Fridriksson, C Rorden, J Elm, S Sen, MS George, L Bonilha
JAMA neurology 75 (12), 1470-1476, 2018
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial
K Kieburtz, BC Tilley, JJ Elm, D Babcock, R Hauser, GW Ross, ...
Jama 313 (6), 584-593, 2015
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design
SC Johnston, JD Easton, M Farrant, W Barsan, H Battenhouse, R Conwit, ...
International Journal of Stroke 8 (6), 479-483, 2013
Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin scale
N Chaisinanunkul, O Adeoye, RJ Lewis, JC Grotta, J Broderick, TG Jovin, ...
Stroke 46 (8), 2238-2243, 2015
Oral anticoagulation and functional outcome after intracerebral hemorrhage
A Biffi, JB Kuramatsu, A Leasure, H Kamel, C Kourkoulis, K Schwab, ...
Annals of neurology 82 (5), 755-765, 2017
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
L Neurol
Lancet Neurol 14 (8), 795-803, 2015
The established status epilepticus trial 2013
T Bleck, H Cock, J Chamberlain, J Cloyd, J Connor, J Elm, N Fountain, ...
Epilepsia 54, 89-92, 2013
Fall frequency and risk assessment in early Parkinson's disease
TS Voss, JJ Elm, CL Wielinski, MJ Aminoff, D Bandyopadhyay, KL Chou, ...
Parkinsonism & related disorders 18 (7), 837-841, 2012
Pilot study of intravenous glyburide in patients with a large ischemic stroke
KN Sheth, WT Kimberly, JJ Elm, TA Kent, P Mandava, AJ Yoo, G Thomalla, ...
Stroke 45 (1), 281-283, 2014
Glyburide is associated with attenuated vasogenic edema in stroke patients
WT Kimberly, TWK Battey, L Pham, O Wu, AJ Yoo, KL Furie, AB Singhal, ...
Neurocritical care 20, 193-201, 2014
Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus
JT Connor, JJ Elm, KR Broglio, Esett and Adapt-It Investigators
Journal of clinical epidemiology 66 (8), S130-S137, 2013
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs
BC Tilley, YY Palesch, K Kieburtz, B Ravina, P Huang, JJ Elm, K Shannon, ...
Neurology 66 (5), 628-633, 2006
O sistema não pode efectuar a operação agora. Tente mais tarde.
Artigos 1–20